Positive COVID-19 Data Gives This Stock a Boost

Good morning Wake-Up Watchlisters! It’s Monday, and you know what means. Our Head Trading Tactician Nate Bear is giving you his weekly stocks to watch. Today he’s got three names he wants to go over. You won’t want to miss this one. Click the image below to see what’s in store this week.

And while you’re sipping coffee you’ll see stock futures were up again on Monday. The markets are looking to sustain Friday’s big rally, which saw all three major indexes soar. This upward trend came after signs of cooling wage growth from December employment data. For the week, the S&P 500 and Dow Jones Industrial Average each advanced 1.5%.

Attention Traders: We’ve got huge news. We have a new technology that’s more than 20 years in the making. This new tool could help you find winning trade patterns faster than ever. And we’re going to show you exactly how it works for FREE on Wednesday, January 11 at 2 p.m. EST.

Click here to get on the guest list for our Accelerated Profits Summit Live.

Here’s a look at the top-moving stocks this morning.

CureVac N.V. (Nasdaq: CVAC)

CureVac N.V. is up 27% premarket after new preliminary data from its early stage trial of COVID-19 and seasonal flu shots showed positive results. CureVac said the COVID-19 shot was well tolerated, and that neutralizing antibodies were beginning at the lowest tested dose for younger adults.

When it comes to investing in innovative medical companies, it’s crucial to consider companies that haven’t popped yet. That’s why our friend Alexander Green is pounding the table on a company that has the patent on a medical device that could be the biggest breakthrough in 37 years – and it’s trading for under $3 right now.

Click here to unlock this stock.

Exact Sciences (Nasdaq: EXAS)

Exact Sciences is up 14% premarket after announcing its latest fourth quarter results. The leading cancer screening company posted a 28% revenue increase compared to the fourth quarter 2021. It also announced expected revenue between $550.7 million and $552.7 million, an increase of 16%.

Lululemon Athletica (Nasdaq: LULU)

Lululemon is down 12.22% premarket after the clothing retailer said it now expects gross margin for its fourth quarter fiscal 2022 to decline by 90-110 basis points, having previously expected an increase of 10-20 basis points. The company’s gross margin in the fourth quarter of fiscal 2023 was 58.1%.

Those are the top market movers today.

Happy trading!

The Wake-Up Watchlist Research Team